News

The prospectively designed, head-to-head clinical trials will provide important information to physicians, patients, caregivers, and payors to make informed choices, said the company. Shire Specialty Pharmaceuticals and Regenerative

As per the agreement, the companies aim to develop and commercialize at least three new vaccines with MTPC who will provide funding for all research and development costs.

Stealth decided to move forward with Unigene’s platform following the data of an oral feasibility study for its pipeline candidate using the latter’s oral delivery technology relative to

This open-label Phase II study will evaluate the efficacy, pharmacodynamics, safety and tolerability of oral BL-7040 in up to 20 patients with moderately active ulcerative colitis, a type

The additional space will be used to the build a second GMP manufacturing clean room suite and space for team members. BioLife Solutions chief executive officer Mike Rice

The investment sees the company expand its containment facilities with a 15,000sq ft new development and commercial manufacturing unit for tablets and capsules. The new facility will enable

Medicyte is a company involved in the generation of human primary cells based on the upcyte technology, while Primacyt is a firm involved in long-term culturing of primary

Plandaí chief executive officer Roger Duffield said the anecdotal benefits of green tea have been known for centuries, with herbalists using it to benefit cardiovascular health and help

As per the agreement, Abbott manufactures all dosage strengths of the authorized generic product and supplies to Watson. Watson markets and distributes the product in the US and